IT
InterAct Therapeutics, Inc.
SEC filingOther Health Care · Dallas, TX
Amount raised$250Ksold at filing
Total offering$2M$1.8M still open
Investors in the raise1count reported to the SEC
FiledJul 21, 2026first sale Jul 20, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Isaac ChanDirector
Daniel HargroveExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.